COMPARISON OF EFFICACY OF STEROIDS ALONE AND COMBINATION OF STEROIDS WITH HYALURONIDASE ON MOUTH OPENING IN ORAL SUBMUCOUS FIBROSIS PATIENTS
Keywords:Hyaluronidase, intarlesional, oral submucous fibrosis, puncture technique., limited mouth opening
AbstractBackground: Eventually Oral submucous fibrosis causes pronounced stiffness and failure to open the mouth. Objectives are to determine compare the efficacy of intralesional steroids alone and combination of steroids with hyaluronidase on mouth opening in oral submucous fibrosis. Methods: It was a prospective comparative cohort study. Total of 74 patients both male and female having history of pan chewing and limited mouth opening and burning sensations were included in the study. Informed consent was taken and divided into two groups. Patients of group 1 were managed with mixture of betamethasone 1 ml and hyaluronidase 1500 IU and patients of group 2 were treated with only steroid injection of betamethasone 1 ml given intralesional, both injections were given intralesional, by multiple puncture technique and once a week and continued for twelve weeks (3 months). And data compiled and analyzed in SPSS-20. Results: The mean age of group 1 was 40.027±6.97years, and mean age of Group 2 was 37.351±5.48 years. In both groups, the greatest number of cases aged from 31–59 years. Compared to females in both groups, the majority of patients were males. In 32 (86.4)% patients of group 1 showed efficacy compared with 18[43.2] patients in group 2 [p-0.000]. Conclusion: In this study Intralesional steroids with hyaluronidase injections are more efficient for opening the mouth in patients with oral sub-mucus fibrosis.
Xu Z, Lü FY, Jiang EH, Zhao XP, Shang ZJ. Relationship among areca nut, intracellular reactive oxygen species, and autophagy. Hua Xi Kou Qiang Yi Xue Za Zhi 2020;38(1):80–5.
Ray JG, Chatterjee R, Chaudhuri K. Oral submucous fibrosis: a global challenge. Rising incidence, risk factors, management, and research priorities. Periodontology 2000 2019;80(1):200–12.
Wadhwan V, Venkatesh A, Reddy V, Malik S. The role of myofibroblasts in the progression of oral submucous fibrosis: a systematic review. J Oral Maxillofac Pathol 2019;23(2):257–66.
Mahato B, Prodhan C, Mandal S, Dutta A, Kumar P, Deb T, et al. Evaluation of efficacy of curcumin along with lycopene and piperine in the management of oral submucous fibrosis. Contemp Clin Dent 2019;10(3):531–41.
Phulari RGS, Dave EJ. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis. Eur J Cancer Prev 2020;29(5):470–3.
Jain A, Taneja S. Oral submucous fibrosis in pediatric patients: a systematic review and protocol for management. Int J Surg Oncol 2019;2019:3497136.
Chaurasia A, Singh N, Sahu D, Mishra A. Comparative Evaluation of role of Lysyl oxidase gene (LOXG473A) expression in pathogenesis and malignant transformation of Oral Submucous Fibrosis. J Clin Exp Dent 2019;11(10):e858.
Johny J, Bhagvandas SC, Mohan SP, Punathil S, Moyin S, Bhaskaran MK. Comparison of efficacy of lycopene and lycopene–hyaluronidase combination in the treatment of oral submucous fibrosis. J Pharm Bioallied Sci 2019;11(Suppl 2):S260–4.
Thakkannavar SS, Naik VV. Histochemical and Immunohistochemical Analysis of Collagen Fibers and Microvascular Density in Various Grades of Oral Submucous Fibrosis. Iran J Pathol 2019;14(2):127–34.
Trivedy C, Meghji S, Warnakulasuriya KA, Johnson NW, Harris M. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral sub-mucous fibrosis. J Oral Pathol Med 2001;30(8):465–70.
Ali SM, Qureshi R, Jamal S. Prevalence of oral submucous fibrosis and use of tobacco and related products amongst school going males. Pak Oral Dent J 2011;31(2):384–7.
Xie H, Guo J, Tan B, Wu H. Efficacy of Salvia miltiorrhiza injection combined with steroids in the treatment of oral submucous fibrosis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2019;98(27)e16339.
Guo J, Xie H, Mao S, Liang M, Wu H. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials. J Oral Pathol Med 2020;49(4):311–9.
Daga D, Singh RK, Pal US, Gurung T, Gangwar S. Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis. Nat J Maxillofac Surg 2017;8(1):50–4.
Adtani PN, Narasimhan M, Punnoose AM, Kambalachenu HR. Antifibrotic effect of centella asiatica linn and asiatic acid on arecoline-induced fibrosis in human buccal fibroblasts. J Investig Clin Dent 2017;8(2):e12208.
Shah PH, Venkatesh R, More CB, Vassandacoumara V. Comparison of therapeutic efficacy of placental extract with dexamethasone and hyaluronic acid with dexamethasone for oral submucous fibrosis—A retrospective analysis. J Clin Diagn Res 2016;10:ZC63–6.
Xiao YC, Jian XC, Zheng L, Zhou C, Du YX. Methods and effects of injection of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Shanghai Kou Qiang Yi Xue 2017;26(2):188–92.
Tilakaratne WM, Ekanayaka RP, Herath M, Jayasinghe RD, Sitheeque M, Amarasinghe H. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122(2):224–31.
Shetty P, Shenai P, Chatra L, Rao PK. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis. Indian J Dent Res 2013;24:347–50.
Haque MF, Meghi S, Nazir R. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathol Med 2011;30(1):12–21.
Dani VB, Patel SH. The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian J Cancer 2018;55(3):248–50.
Frame JW. Carbon dioxide laser surgery for benign oral lesions. Br Dent J 1985;158(4):125–8.
Bachmann A, Ruszat R. The KTP-(greenlight-) laser-principles and experiences. Minim Invasive Ther Allied Technol 2007;16(1):5–10.
Li YH, Liu CC, Chiang TE, Chen YW. EZBite open-mouth device: a new treatment option for oral submucous fibrosis-related trismus. J Dent Sci 2018;13(1):80–1.
Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991;49(8):788–91.